Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Changes in Shareholders' Equity (Deficiency)

v3.10.0.1
Condensed Consolidated Interim Statements of Changes in Shareholders' Equity (Deficiency) - USD ($)
Total
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Deficit [Member]
Accumulated Other Comprehensive Income [Member]
Opening Balance at Mar. 31, 2017 $ 24,150,650 $ 0 $ 96,794 $ 45,088,171 $ (21,076,464) $ 42,149
Opening Balance (in shares) at Mar. 31, 2017   1 96,794,443      
Warrants exercised 1,125,038 $ 0 $ 5,000 1,120,038 0 0
Warrants exercised (in shares)   0 5,000,172      
Share compensation expense 251,048 $ 0 $ 0 251,048 0 0
Share compensation expense (in shares)   0 0      
Fair value of warrants on convertible loans 204,790 $ 0 204,790 0 0
Net loss for the period (2,240,518)       (2,240,518)  
Closing Balance at Jun. 30, 2017 23,491,008 $ 0 $ 101,794 46,664,047 (23,316,982) 42,149
Closing Balance (in shares) at Jun. 30, 2017   1 101,794,615      
Opening Balance at Mar. 31, 2017 24,150,650 $ 0 $ 96,794 45,088,171 (21,076,464) 42,149
Opening Balance (in shares) at Mar. 31, 2017   1 96,794,443      
Closing Balance at Mar. 31, 2018 20,463,014 $ 0 $ 249,599 55,947,606 (35,776,340) 42,149
Closing Balance (in shares) at Mar. 31, 2018   1 249,599,986      
Opening Balance at Jun. 30, 2017 23,491,008 $ 0 $ 101,794 46,664,047 (23,316,982) 42,149
Opening Balance (in shares) at Jun. 30, 2017   1 101,794,615      
Warrant down round feature 0 $ 0 $ 0 74,086 (74,086) 0
Share compensation expense 1,289,532     1,289,532    
Share compensation expense (in shares)   0        
Conversion of convertible notes 9,180,785 $ 0 $ 147,805 9,032,980 0 0
Conversion of convertible notes (in shares)   0 147,805,371      
Fair value of warrants on convertible loans 343,389     343,389    
Stock option and warrant reclassification (2,845,557) $ 0 $ 0 (2,845,557) 0 0
Beneficial conversion feature on convertible debt 1,389,129 0 0 1,389,129 0 0
Net loss for the period (12,385,272)       (12,385,272)  
Closing Balance at Mar. 31, 2018 20,463,014 $ 0 $ 249,599 55,947,606 (35,776,340) 42,149
Closing Balance (in shares) at Mar. 31, 2018   1 249,599,986      
Share compensation expense 595,412 $ 0   595,412 0 0
Share compensation expense (in shares)   0 0      
Conversion of convertible notes 2,470,622 $ 0 $ 39,546 2,431,076 0 0
Conversion of convertible notes (in shares)   0 39,545,776      
Stock option and warrant reclassification 1,173,534 $ 0 $ 0 1,173,534 0 0
Net loss for the period (760,698)       (760,698)  
Closing Balance at Jun. 30, 2018 $ 23,941,884 $ 0 $ 289,145 $ 60,147,628 $ (36,537,038) $ 42,149
Closing Balance (in shares) at Jun. 30, 2018   1 289,145,762